Stipple Bio

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to unlock cellular profiling and target discovery. Stipple Bio is based in Cambridge, MA and was founded in 2022. It was valued at $2.2 billion at its early-stage round in Apr 2026, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $65.1 million later-stage round in Mar 2026.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
its early-stage round
Apr 2026
Total raised
$121.5M
Last round
Later Stage VC
Mar 2026
What is Stipple Bio worth?
$2.2BPrivateMarketView mark · Oct 2026

Valued at $2.2B at its early-stage round, Apr 2026. Nothing has traded since.

Free account
More of Stipple Bio with a free account
  • ·Watch Stipple Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Stipple Bio funding history

2 rounds
DateRoundRaisedPost-money
Mar 2026Later Stage VC$65.1M▮
Dec 2024Early Stage VC$9.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Stipple Bio valuation

Stipple Bio was valued at $2.2 billion at its early-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Stipple Bio raised?

Stipple Bio has raised $121 million in total; 2 of its rounds are on record. The largest on record was a $9.5 million early-stage round in Dec 2024; the most recent was a $65.1 million later-stage round in Mar 2026.

Stipple Bio has filed 1 Form D with the SEC, most recently in Dec 2024 ($9.5 million sold to 1 investor).

How Stipple Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Stipple Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Stipple Bio

What is Stipple Bio worth?
Stipple Bio is valued at $2.2B as of Oct 2026. Valued at $2.2B at its early-stage round, Apr 2026. Nothing has traded since.
How much has Stipple Bio raised?
Stipple Bio has raised $121.5M in total funding across 2 recorded rounds.
When did Stipple Bio last raise?
Stipple Bio last raised in Mar 2026 (Later Stage VC), raising $65.1M.